{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:29:35Z","timestamp":1770913775702,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006193","name":"Kuwait University College of Graduate Studies","doi-asserted-by":"publisher","award":["YM06\/18"],"award-info":[{"award-number":["YM06\/18"]}],"id":[{"id":"10.13039\/501100006193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","award":["GS01\/03"],"award-info":[{"award-number":["GS01\/03"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejphar.2022.175265","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T01:42:25Z","timestamp":1662946945000},"page":"175265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"933","author":[{"given":"Hussa","family":"Alshahwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedoor","family":"Qabazard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyaa","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Santhosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam H.M.","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejphar.2022.175265_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141657","article-title":"Transactivation of ErbB family of receptor tyrosine kinases is inhibited by angiotensin-(1-7) via its mas receptor","volume":"10","author":"Akhtar","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175265_bib2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1476-5381.2011.01613.x","article-title":"Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway","volume":"165","author":"Akhtar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175265_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-444-53480-4.00015-1","article-title":"General aspects of diabetes mellitus","volume":"126","author":"Alam","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175265_bib4","first-page":"ra87","article-title":"The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide","volume":"322","author":"Altaany","year":"2014","journal-title":"Sci. Signal."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175265_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jcmm.12077","article-title":"Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells","volume":"17","author":"Altaany","year":"2013","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175265_bib6","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.3390\/molecules191221183","article-title":"Hydrogen sulfide and endothelium-dependent vasorelaxation","volume":"19","author":"Be\u0142towski","year":"2014","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175265_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0706238","article-title":"Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed","volume":"145","author":"Benter","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175265_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000085904","article-title":"Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase","volume":"42","author":"Benter","year":"2005","journal-title":"J. Vasc. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175265_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bjp.2008.296","article-title":"Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice","volume":"155","author":"Brancaleone","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175265_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053319","article-title":"cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation","volume":"7","author":"Bucci","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175265_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diabetes.52.3.634","article-title":"Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression","volume":"52","author":"Carlson","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2022.175265_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-4-3","article-title":"Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction","volume":"4","author":"Chen","year":"2005","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175265_bib13","doi-asserted-by":"crossref","first-page":"H2316","DOI":"10.1152\/ajpheart.00331.2004","article-title":"Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats","volume":"287","author":"Cheng","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/molmed.2015.00035","article-title":"Regulation of vascular tone, angiogenesis and cellular bioenergetics by the 3-mercaptopyruvate sulfurtransferase\/H2S pathway: functional impairment by hyperglycemia and restoration by DL-\u03b1-lipoic acid","volume":"21","author":"Coletta","year":"2015","journal-title":"Mol. Med."},{"issue":"23","key":"10.1016\/j.ejphar.2022.175265_bib15","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.110.176016","article-title":"Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed","volume":"337","author":"D'Emmanuele di Villa Bianca","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175265_bib17","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1073\/pnas.0807974105","article-title":"Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation","volume":"106","author":"D\u2019 Emmanuele di Villa Bianca","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2022.175265_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5084961","article-title":"Angiotensin-(1-7) downregulates diabetes-induced cGMP phosphodiesterase activation in rat corpus cavernosum","author":"Dhaunsi","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ab.2005.03.024","article-title":"Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues","volume":"341","author":"Doeller","year":"2005","journal-title":"Anal. Biochem."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175265_bib20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.0000133428.02295.6C","article-title":"Protein kinase c\u03b2 isoform inhibitors. A new treatment for diabetic cardiovascular diseases","volume":"110","author":"He","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.115.227017","article-title":"Involvement of potassium channels and calcium-dependent mechanisms in hydrogen sulfide-induced relaxation of rat mesenteric small arteries","volume":"356","author":"Hedegaard","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175265_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/bbrc.1997.6878","article-title":"The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide","volume":"237","author":"Hosoki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175265_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI3326","article-title":"Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways","volume":"103","author":"Igarashi","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175265_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.bjp.0705611","article-title":"Contribution of nitric oxide produced by inducible nitric oxide synthase to vascular responses of mesenteric arterioles in streptozotocin-diabetic rats","volume":"141","author":"Ishikawa","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175265_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1089\/ars.2009.2956","article-title":"Low levels of hydrogen sulfide in the blood of diabetes patients and streptozocine-treated rats causes vascular inflammation","volume":"12","author":"Jain","year":"2010","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175265_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI5971","article-title":"Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats","volume":"104","author":"Jiang","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2022.175265_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.175265_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.2040-1124.2010.00018.x","article-title":"Molecular mechanisms of diabetic vascular complications","volume":"1","author":"Kitada","year":"2010","journal-title":"J. Diabetes Investig."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175265_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.CIR.101.6.676","article-title":"Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin","volume":"101","author":"Kuboki","year":"2000","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ejphar.2022.175265_bib31","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide\u2013releasing molecule (GYY4137) new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175265_bib32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/bph.12246","article-title":"The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E\u2212\/\u2212 mice","volume":"169","author":"Liu","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175265_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ijir.2012.39","article-title":"Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase","volume":"25","author":"Meng","year":"2013","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.ejphar.2022.175265_bib34","first-page":"1015","article-title":"Mitigating micro and macro-vascular complications of diabetes beginning in adolescence","volume":"5","author":"Moore","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175265_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1210\/en.2008-1069","article-title":"Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature","volume":"150","author":"Nacci","year":"2009","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175265_bib36","doi-asserted-by":"crossref","first-page":"H2144","DOI":"10.1152\/ajpheart.00591.2005","article-title":"Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes","volume":"289","author":"Nagareddy","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"31","key":"10.1016\/j.ejphar.2022.175265_bib37","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part 1","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur. Heart J."},{"issue":"51","key":"10.1016\/j.ejphar.2022.175265_bib38","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2022.175265_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110210","article-title":"H2S donor GYY4137 ameliorates paclitaxel-induced neuropathic pain in mice","volume":"127","author":"Qabazard","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.175265_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111486","article-title":"GYY4137 attenuates functional impairment of corpus cavernosum and reduces fibrosis in rats with STZ-induced diabetes by inhibiting the TGF-\u03b21\/Smad\/CTGF Pathway","volume":"138","author":"Qabazard","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.175265_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41443-018-0083-x","article-title":"Alleviation of impaired reactivity in the corpus cavernosum of STZ-diabetic rats by slow-release H2S donor GYY4137","volume":"31","author":"Qabazard","year":"2019","journal-title":"Int. J. Impot. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175265_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1871530318666180426100532","article-title":"Hydrogen sulfide in diabetic complications: focus on molecular mechanisms","volume":"18","author":"Qian","year":"2018","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2022.175265_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jss.2017.12.030","article-title":"GYY4137 protects against myocardial ischemia\/reperfusion injury via activation of the PHLPP-1\/Akt\/Nrf 2 signaling pathway in diabetic mice","volume":"225","author":"Qiu","year":"2017","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175265_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00018-012-1198-8","article-title":"Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab 1\/PI3K\/Akt transduction pathway","volume":"70","author":"Rodriguez-Araujo","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175265_bib45","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnen\/nlaa127","article-title":"Chronic treatment with hydrogen sulfide donor GYY4137 mitigates microglial and astrocyte activation in the spinal cord of streptozotocin-induced diabetic rats","volume":"79","author":"Shayea","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.redox.2012.11.006","article-title":"Redox biology of hydrogen sulfide: implications for physiology, pathophysiology, and pharmacology","volume":"1","author":"Stein","year":"2012","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175265_bib47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj2060267","article-title":"Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat","volume":"206","author":"Stipanuk","year":"1982","journal-title":"Biochem. J."},{"issue":"33","key":"10.1016\/j.ejphar.2022.175265_bib48","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1073\/pnas.1105121108","article-title":"Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function","volume":"108","author":"Suzuki","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/ars.2011.4451","article-title":"Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications","volume":"17","author":"Szabo","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"Tabit","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ejphar.2022.175265_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implication of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175265_bib52","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tips.2015.05.007","article-title":"The role of H2S bioavailability in endothelial dysfunction","volume":"36","author":"Wang","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exer.2012.01.014","article-title":"Using the Griess colorimetric nitrite assay for measuring aliphatic \u03b2-nitroalcohols","volume":"98","author":"Wen","year":"2012","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175265_bib54","first-page":"451","article-title":"Phosphoinositide 3-kinase contributes to diabetes-induced abnormal vascular reactivity in rat perfused mesenteric bed. Cell Biochem","volume":"26","author":"Yousif","year":"2008","journal-title":"Funct"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175265_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1474-8673.2003.00282.x","article-title":"Inhibition of calcium\/calmodulin\u2010dependent protein kinase II normalizes diabetes\u2010induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed","volume":"23","author":"Yousif","year":"2003","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175265_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-8673.2004.00333.x","article-title":"The role of tyrosine kinase-mediated pathways in diabetes-induced alteration in responsiveness of rat carotid artery","volume":"25","author":"Yousif","year":"2004","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175265_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cbf.1278","article-title":"Phosphoinositide 3-kinase mediated signaling contributes to development of diabetes-induced abnormal vascular reactivity of rat carotid artery","volume":"24","author":"Yousif","year":"2006","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejphar.2022.175265_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.07.012","article-title":"Hydrogen sulfide as a potent cardiovascular protective agent","volume":"437","author":"Yu","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175265_bib59","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.06.021","article-title":"Streptozocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis","volume":"333","author":"Yusuf","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175265_bib60","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00013.2002","article-title":"H2S-induced vasorelaxation and underlying cellular and molecular mechanisms","volume":"283","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"80","key":"10.1016\/j.ejphar.2022.175265_bib61","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1039\/C4CC00968A","article-title":"Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications","volume":"50","author":"Zhao","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejphar.2022.175265_bib62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992200526X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992200526X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:20:12Z","timestamp":1762143612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992200526X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":62,"alternative-id":["S001429992200526X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175265","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175265"}}